Marlene Debel - Feb 24, 2022 Form 4 Insider Report for RAYMOND JAMES FINANCIAL INC (RJF)

Role
Director
Signature
/s/ Marlene Debel by Jonathan J. Doyle as Attorney-in-Fact
Stock symbol
RJF
Transactions as of
Feb 24, 2022
Transactions value $
$0
Form type
4
Date filed
2/25/2022, 02:08 PM
Previous filing
Feb 24, 2022
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RJF Common Stock Options Exercise $0 +1.93K +318.18% $0.00 2.53K Feb 24, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RJF Restricted Stock Units Award $0 +1.68K +87.43% $0.00 3.61K Feb 24, 2022 Common Stock 1.68K Direct F1, F2
transaction RJF Restricted Stock Units Options Exercise $0 -1.93K -53.35% $0.00 1.68K Feb 24, 2022 Common Stock 1.93K Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends.
F2 The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2023.
F3 The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant.
F4 The RSU grant was previously reported as covering 1,283 shares awarded on February 18, 2021, but was adjusted to reflect the 3-for-2 stock split by means of a stock dividend that occurred on September 21, 2021.

Remarks:

This Form 4 reports (i) the acquisition by the reporting person of RSUs resulting from an annual grant to the registrant's non-executive directors and (ii) the vesting of RSUs awarded to the reporting person.